Clinical Trial

Synthetic PET From CT Improves Precision Diagnosis and Treatment of Lung Cancer: a Prospective, Observational, Multicenter Study

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 24, 2025 (before its estimated June 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study aims to synthesise PET data that preserves biological relevance and adds clinical value to the diagnosis and prognosis of lung cancer by establishing anatomical-to-metabolic mapping based on paired diagnostic CT and FDG-PET scans, thereby prospectively validating the clinical utility of the model.
Trial Details
NCT Number NCT07243873
Lead Sponsor Shanghai Pulmonary Hospital, Shanghai, China
Conditions Lung Cancer, PET-CT
Enrollment 10,000 participants
Start Date 2025-12-01
Primary Completion 2026-06-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-11-24